Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 3/20 | 0.52 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.52 |
| ▸ | ESR1 | P03372 | 12/20 | 0.50 |
| ▸ | ESR2 | Q92731 | 11/20 | 0.50 |
| ▸ | SLC7A5 | Q01650 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10630272 | 0.81 | SLC6A2 (0.50) | SLC6A2 | |
| SCHEMBL6473879 | 0.80 | TRPA1 (0.52) | TAAR1SLC6A2 | |
| SCHEMBL6478746 | 0.80 | TRPA1 (0.52) | TAAR1SLC6A2 | |
| SCHEMBL6473888 | 0.80 | TRPA1 (0.52) | TAAR1SLC6A2 | |
| SCHEMBL5424462 | 0.80 | TAAR1 (0.54) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL20132817 | 0.78 | TAAR1 (0.57) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL9905877 | 0.77 | TAAR1 (0.61) | TAAR1SLC6A2ESR1ESR2SLC7A5 | |
| SCHEMBL14255722 | 0.77 | CYP3A4 (0.66) | SLC6A2 | |
| SCHEMBL20673669 | 0.77 | TAAR1 (0.67) | TAAR1SLC6A2ESR1ESR2 | |
| SCHEMBL20673668 | 0.77 | TAAR1 (0.67) | TAAR1SLC6A2ESR1ESR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6515051-B2 | Stability and durability and a low loss rate when incorporated into automotive coatings; soluble in a variety of substrates including thermoplastic polymers and often are colorless | CIBA SPECIALTY CHEMICALS CORPORATION | 2003-02-04 | — | — | US | disclosed |
| US-20020099221-A1 | Benzotriazole UV absorbers having enhanced durability | RAVICHANDRAN RAMANATHAN (US) | 2002-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20020099221-A1 | Benzotriazole UV absorbers having enhanced durability | TERT, AHR, ARNT | TAAR1 1202/4885SLC6A2 2102/4885ESR1 703/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.